FMED vs. ENVB
FMED (Fidelity Disruptive Medicine ETF) is Health & Biotech Equities fund actively managed by Fidelity, while ENVB (Enveric Biosciences Inc) is a stock. Over the past 3 years, FMED returned 0.73%/yr vs -87.52%/yr for ENVB. At a 0.24 correlation, their price movements are largely independent.
Performance
FMED vs. ENVB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FMED achieves a -4.75% return, which is significantly higher than ENVB's -59.23% return.
FMED
- 1D
- 0.90%
- 1M
- 7.10%
- YTD
- -4.75%
- 6M
- -6.17%
- 1Y
- 8.53%
- 3Y*
- 0.73%
- 5Y*
- —
- 10Y*
- —
ENVB
- 1D
- -3.27%
- 1M
- -34.22%
- YTD
- -59.23%
- 6M
- -72.39%
- 1Y
- -89.81%
- 3Y*
- -87.52%
- 5Y*
- -85.10%
- 10Y*
- -74.86%
FMED vs. ENVB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
FMED Fidelity Disruptive Medicine ETF | -4.75% | 9.69% | 2.29% | -3.59% |
ENVB Enveric Biosciences Inc | -59.23% | -94.37% | -72.43% | -65.79% |
Correlation
The correlation between FMED and ENVB is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Jun 12, 2023 | 0.24 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FMED vs. ENVB — Risk / Return Rank
FMED
ENVB
FMED vs. ENVB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Disruptive Medicine ETF (FMED) and Enveric Biosciences Inc (ENVB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FMED | ENVB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.96 | ||
| Sortino ratioReturn per unit of downside risk | +1.80 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 0.87 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 0.47 | -0.98 | +1.45 |
| Martin ratioReturn relative to average drawdown | 1.03 | -1.34 | +2.38 |
Loading charts...
Drawdowns
FMED vs. ENVB - Drawdown Comparison
The maximum FMED drawdown since its inception was -21.84%, smaller than the maximum ENVB drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for FMED and ENVB.
Loading charts...
Drawdown Indicators
| FMED | ENVB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -21.84% | -100.00% | +78.16% |
Max Drawdown (1Y)Largest decline over 1 year | -18.33% | -91.49% | +73.16% |
Max Drawdown (3Y)Largest decline over 3 years | -21.84% | -99.81% | +77.97% |
Max Drawdown (5Y)Largest decline over 5 years | — | -100.00% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -100.00% | — |
Current DrawdownCurrent decline from peak | -10.64% | -100.00% | +89.36% |
Average DrawdownAverage peak-to-trough decline | -7.09% | -86.07% | +78.98% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.27% | 66.73% | -58.46% |
Volatility
FMED vs. ENVB - Volatility Comparison
The current volatility for Fidelity Disruptive Medicine ETF (FMED) is 7.50%, while Enveric Biosciences Inc (ENVB) has a volatility of 21.07%. This indicates that FMED experiences smaller price fluctuations and is considered to be less risky than ENVB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FMED | ENVB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.50% | 21.07% | -13.57% |
Volatility (6M)Calculated over the trailing 6-month period | 15.01% | 105.59% | -90.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.37% | 175.01% | -155.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.57% | 155.96% | -137.39% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.57% | 164.65% | -146.08% |
Dividends
FMED vs. ENVB - Dividend Comparison
Neither FMED nor ENVB has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
ENVB Enveric Biosciences Inc | 0.00% | 0.00% | 0.00% |
FMED Fidelity Disruptive Medicine ETF | 0.00% | 0.00% | 0.46% |
Frequently Asked Questions
FMED and ENVB have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENVB has higher volatility (21.07%) compared to FMED (7.50%). In terms of maximum drawdown, FMED dropped -21.84% vs ENVB's -100.00%.
FMED currently has the higher Sharpe Ratio (0.44 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FMED and ENVB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer